Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,190) with videos related to
Page
of 119
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2019
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update
Kala Visvanathan, Carol J Fabian, Elissa Bantug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2011
Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer
Joseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2011
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
Kideok Jin, Xiangjun Kong, Tariq Shah, et al.
Plos One
|
June 14, 2019
Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A
Delphine Bachelet, Thilo Albert, Cyprien Mbogning, et al.
Ophthalmology
|
October 24, 2013
Retinal structure and function in achromatopsia: implications for gene therapy
Venki Sundaram, Caroline Wilde, Jonathan Aboshiha, et al.
Human Molecular Genetics
|
May 24, 2012
Deep intronic mutation in OFD1, identified by targeted genomic next-generation sequencing, causes a severe form of X-linked retinitis pigmentosa (RP23)
Tom R Webb, David A Parfitt, Jessica C Gardner, et al.
American Journal of Human Genetics
|
October 27, 2009
Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa
Alice E Davidson, Ian D Millar, Jill E Urquhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 8, 2013
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial
Edith A Perez, Amylou C Dueck, Ann E McCullough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
Sylvia Adams, Robert J Gray, Sandra Demaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Bryan P Schneider, Fei Shen, Laura Gardner, et al.
Page
of 119
Search research articles
Search
Showing results (1071-1080 of 1,190) with videos related to
Sort By:
Page
of 119
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2019
Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update
Kala Visvanathan, Carol J Fabian, Elissa Bantug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2011
Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer
Joseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2011
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
Kideok Jin, Xiangjun Kong, Tariq Shah, et al.
Plos One
|
June 14, 2019
Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A
Delphine Bachelet, Thilo Albert, Cyprien Mbogning, et al.
Ophthalmology
|
October 24, 2013
Retinal structure and function in achromatopsia: implications for gene therapy
Venki Sundaram, Caroline Wilde, Jonathan Aboshiha, et al.
Human Molecular Genetics
|
May 24, 2012
Deep intronic mutation in OFD1, identified by targeted genomic next-generation sequencing, causes a severe form of X-linked retinitis pigmentosa (RP23)
Tom R Webb, David A Parfitt, Jessica C Gardner, et al.
American Journal of Human Genetics
|
October 27, 2009
Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa
Alice E Davidson, Ian D Millar, Jill E Urquhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 8, 2013
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial
Edith A Perez, Amylou C Dueck, Ann E McCullough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199
Sylvia Adams, Robert J Gray, Sandra Demaria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2016
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure
Bryan P Schneider, Fei Shen, Laura Gardner, et al.
Page
of 119